Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Arthri-D3 Name Remains After Testimonials Vanish During NAD Review

This article was originally published in The Tan Sheet

Executive Summary

NAD attorneys agree with CRN that the Arthri-D3 brand, when used in conjunction with testimonials related to relief from arthritis pain, “might convey the misleading message that Arthri-D3 immediately and completely relieves arthritis pain.” However, Arthri-D LLC discontinues the challenged testimonials.

You may also be interested in...



Athlete's Foot Firm Kicks Back On NAD Finding That Brand Is A Fungal Claim

Kramer Laboratories' claims for Fungi-Nail athlete's foot product referred to FDA and FTC after it refuses to comply with NAD's recommendation to modify the name. The firm, which agreed to modify packaging and commercial claims, was warned by FDA about the brand in 2005.

Athlete's Foot Firm Kicks Back On NAD Finding That Brand Is A Fungal Claim

Kramer Laboratories' claims for Fungi-Nail athlete's foot product referred to FDA and FTC after it refuses to comply with NAD's recommendation to modify the name. The firm, which agreed to modify packaging and commercial claims, was warned by FDA about the brand in 2005.

P&G Supports Crest Sensi-Stop Strips Claims In More Than Name Only – NAD

P&G’s Crest Sensi-Stop Strips emerge largely unscathed from a NAD review of claims made in ads and on product packaging. While GSK argued some claims were unsupported, including the product name, NAD determined P&G’s evidence supports claims of immediate relief and protection for up to one month.

Topics

UsernamePublicRestriction

Register

PS107847

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel